177 related articles for article (PubMed ID: 24678565)
1. Meta-analysis of on-the-road experimental studies of hypnotics: effects of time after intake, dose, and half-life.
Roth T; Eklov SD; Drake CL; Verster JC
Traffic Inj Prev; 2014; 15(5):439-45. PubMed ID: 24678565
[TBL] [Abstract][Full Text] [Related]
2. Hypnotics and driving safety: meta-analyses of randomized controlled trials applying the on-the-road driving test.
Verster JC; Veldhuijzen DS; Patat A; Olivier B; Volkerts ER
Curr Drug Saf; 2006 Jan; 1(1):63-71. PubMed ID: 18690916
[TBL] [Abstract][Full Text] [Related]
3. Residual effects of sleep medication on driving ability.
Verster JC; Veldhuijzen DS; Volkerts ER
Sleep Med Rev; 2004 Aug; 8(4):309-25. PubMed ID: 15233958
[TBL] [Abstract][Full Text] [Related]
4. Residual effects of middle-of-the-night administration of zaleplon and zolpidem on driving ability, memory functions, and psychomotor performance.
Verster JC; Volkerts ER; Schreuder AH; Eijken EJ; van Heuckelum JH; Veldhuijzen DS; Verbaten MN; Paty I; Darwish M; Danjou P; Patat A
J Clin Psychopharmacol; 2002 Dec; 22(6):576-83. PubMed ID: 12454557
[TBL] [Abstract][Full Text] [Related]
5. Zopiclone's residual effects on actual driving performance in a standardized test: a pooled analysis of age and sex effects in 4 placebo-controlled studies.
Leufkens TR; Vermeeren A
Clin Ther; 2014 Jan; 36(1):141-50. PubMed ID: 24360801
[TBL] [Abstract][Full Text] [Related]
6. Highway driving performance and cognitive functioning the morning after bedtime and middle-of-the-night use of gaboxadol, zopiclone and zolpidem.
Leufkens TR; Lund JS; Vermeeren A
J Sleep Res; 2009 Dec; 18(4):387-96. PubMed ID: 19552733
[TBL] [Abstract][Full Text] [Related]
7. Middle-of-the-night administration of sleep medication: a critical review of the effects on next morning driving ability.
Verster JC; van de Loo AJ; Moline ML; Roth T
Curr Drug Saf; 2014; 9(3):205-11. PubMed ID: 24909576
[TBL] [Abstract][Full Text] [Related]
8. Pharmacodynamic profile of Zaleplon, a new non-benzodiazepine hypnotic agent.
Patat A; Paty I; Hindmarch I
Hum Psychopharmacol; 2001 Jul; 16(5):369-392. PubMed ID: 12404558
[TBL] [Abstract][Full Text] [Related]
9. On-the-road driving performance the morning after bedtime use of suvorexant 15 and 30 mg in healthy elderly.
Vermeeren A; Vets E; Vuurman EF; Van Oers AC; Jongen S; Laethem T; Heirman I; Bautmans A; Palcza J; Li X; Troyer MD; Wrishko R; McCrea J; Sun H
Psychopharmacology (Berl); 2016 Sep; 233(18):3341-51. PubMed ID: 27424295
[TBL] [Abstract][Full Text] [Related]
10. Highway driving in the elderly the morning after bedtime use of hypnotics: a comparison between temazepam 20 mg, zopiclone 7.5 mg, and placebo.
Leufkens TR; Vermeeren A
J Clin Psychopharmacol; 2009 Oct; 29(5):432-8. PubMed ID: 19745642
[TBL] [Abstract][Full Text] [Related]
11. Residual effects of low-dose sublingual zolpidem on highway driving performance the morning after middle-of-the-night use.
Vermeeren A; Vuurman EF; Leufkens TR; Van Leeuwen CJ; Van Oers AC; Laska E; Rico S; Steinberg F; Roth T
Sleep; 2014 Mar; 37(3):489-96. PubMed ID: 24587571
[TBL] [Abstract][Full Text] [Related]
12. Next-day effects of ramelteon (8 mg), zopiclone (7.5 mg), and placebo on highway driving performance, memory functioning, psychomotor performance, and mood in healthy adult subjects.
Mets MA; de Vries JM; de Senerpont Domis LM; Volkerts ER; Olivier B; Verster JC
Sleep; 2011 Oct; 34(10):1327-34. PubMed ID: 21966064
[TBL] [Abstract][Full Text] [Related]
13. Antidepressants and driver impairment: empirical evidence from a standard on-the-road test.
Ramaekers JG
J Clin Psychiatry; 2003 Jan; 64(1):20-9. PubMed ID: 12590619
[TBL] [Abstract][Full Text] [Related]
14. Does a medicinal dose of kava impair driving? A randomized, placebo-controlled, double-blind study.
Sarris J; Laporte E; Scholey A; King R; Pipingas A; Schweitzer I; Stough C
Traffic Inj Prev; 2013; 14(1):13-7. PubMed ID: 23259514
[TBL] [Abstract][Full Text] [Related]
15. Zopiclone as positive control in studies examining the residual effects of hypnotic drugs on driving ability.
Verster JC; Spence DW; Shahid A; Pandi-Perumal SR; Roth T
Curr Drug Saf; 2011 Sep; 6(4):209-18. PubMed ID: 22129315
[TBL] [Abstract][Full Text] [Related]
16. Effects of prolonged-release melatonin, zolpidem, and their combination on psychomotor functions, memory recall, and driving skills in healthy middle aged and elderly volunteers.
Otmani S; Demazières A; Staner C; Jacob N; Nir T; Zisapel N; Staner L
Hum Psychopharmacol; 2008 Dec; 23(8):693-705. PubMed ID: 18763235
[TBL] [Abstract][Full Text] [Related]
17. Lapses of attention as outcome measure of the on-the-road driving test.
Verster JC; Bervoets AC; de Klerk S; Roth T
Psychopharmacology (Berl); 2014 Jan; 231(1):283-92. PubMed ID: 23975036
[TBL] [Abstract][Full Text] [Related]
18. Differential residual effects of zaleplon and zopiclone on actual driving: a comparison with a low dose of alcohol.
Vermeeren A; Riedel WJ; van Boxtel MP; Darwish M; Paty I; Patat A
Sleep; 2002 Mar; 25(2):224-31. PubMed ID: 11905433
[TBL] [Abstract][Full Text] [Related]
19. Impact of melatonin, zaleplon, zopiclone, and temazepam on psychomotor performance.
Paul MA; Gray G; Kenny G; Pigeau RA
Aviat Space Environ Med; 2003 Dec; 74(12):1263-70. PubMed ID: 14692469
[TBL] [Abstract][Full Text] [Related]
20. On-the-Road Driving Performance the Morning after Bedtime Use of Suvorexant 20 and 40 mg: A Study in Non-Elderly Healthy Volunteers.
Vermeeren A; Sun H; Vuurman EF; Jongen S; Van Leeuwen CJ; Van Oers AC; Palcza J; Li X; Laethem T; Heirman I; Bautmans A; Troyer MD; Wrishko R; McCrea J
Sleep; 2015 Nov; 38(11):1803-13. PubMed ID: 26039969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
